Keywords: roche/ge, sign, deal, personalized, ad, drugs, swiss

Roche/GE sign deal for personalized AD drugs

Article | 18 July 2005

Print This

Swiss drugmaker Roche and UK group GE Healthcare, formerly known as Amersham before it was acquired for L5.65 billion ($9.93 billion) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in